Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leif-Erik Sander

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Nature Immunology|October 4, 2024
Monocyte-derived macrophages are too much of a good thing in lung fibrosisLeif Erik Sander
Science (New York, N.Y.)|February 22, 2020
Toward a universal flu vaccineSusanne Herold, Leif-Erik Sander
Deutsche Medizinische Wochenschrift (1946)|August 15, 2024
[Vaccinations in pulmonary diseases - part 1: Covid and influenza]Cathrin Kodde, Leif Erik Sander
Deutsche Medizinische Wochenschrift (1946)|October 22, 2024
[Vaccinations in pulmonary diseases - part 2: herpes zoste, RSV, pneumococcal infection and pertussis]Cathrin Kodde, Leif Erik Sander
German Medical Science : GMS E-Journal|July 10, 2023
[The specialty of infectious diseases in German hospitals: position paper of the German Society for Infectiology (DGI)]Gerd Fätkenheuer, Leif Erik Sander, Hortense Slevogt, et al.
Frontiers in Immunology|December 7, 2013
NOD-Like Receptors in Lung DiseasesCatherine Chaput, Leif Erik Sander, Norbert Suttorp, et al.
Infection|June 30, 2022
Incidence and outcomes of SARS-CoV-2-associated PIMS in Germany: a nationwide analysisChristian Karagiannidis, Leif-Erik Sander, Marcus A Mall, et al.
Deutsche Medizinische Wochenschrift (1946)|December 5, 2023
[Vaccinations as a key to pandemic management - Lessons learned from the COVID-19 pandemic]Ngoc Han Le, David Hillus, Pinkus Tober-Lau, et al.
BMC Rheumatology|December 28, 2021
Macrophage activation syndrome in a patient with adult-onset Still's disease following first COVID-19 vaccination with BNT162b2Frédéric Muench, Martin Krusche, Leif Erik Sander, et al.
The Lancet. Infectious Diseases|September 9, 2022
Neutralisation sensitivity of the SARS-CoV-2 omicron BA.2.75 sublineageHenning Gruell, Kanika Vanshylla, Pinkus Tober-Lau, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Nature Immunology|October 4, 2024
Monocyte-derived macrophages are too much of a good thing in lung fibrosisLeif Erik Sander
Science (New York, N.Y.)|February 22, 2020
Toward a universal flu vaccineSusanne Herold, Leif-Erik Sander
Deutsche Medizinische Wochenschrift (1946)|August 15, 2024
[Vaccinations in pulmonary diseases - part 1: Covid and influenza]Cathrin Kodde, Leif Erik Sander
Deutsche Medizinische Wochenschrift (1946)|October 22, 2024
[Vaccinations in pulmonary diseases - part 2: herpes zoste, RSV, pneumococcal infection and pertussis]Cathrin Kodde, Leif Erik Sander
German Medical Science : GMS E-Journal|July 10, 2023
[The specialty of infectious diseases in German hospitals: position paper of the German Society for Infectiology (DGI)]Gerd Fätkenheuer, Leif Erik Sander, Hortense Slevogt, et al.
Frontiers in Immunology|December 7, 2013
NOD-Like Receptors in Lung DiseasesCatherine Chaput, Leif Erik Sander, Norbert Suttorp, et al.
Infection|June 30, 2022
Incidence and outcomes of SARS-CoV-2-associated PIMS in Germany: a nationwide analysisChristian Karagiannidis, Leif-Erik Sander, Marcus A Mall, et al.
Deutsche Medizinische Wochenschrift (1946)|December 5, 2023
[Vaccinations as a key to pandemic management - Lessons learned from the COVID-19 pandemic]Ngoc Han Le, David Hillus, Pinkus Tober-Lau, et al.
BMC Rheumatology|December 28, 2021
Macrophage activation syndrome in a patient with adult-onset Still's disease following first COVID-19 vaccination with BNT162b2Frédéric Muench, Martin Krusche, Leif Erik Sander, et al.
The Lancet. Infectious Diseases|September 9, 2022
Neutralisation sensitivity of the SARS-CoV-2 omicron BA.2.75 sublineageHenning Gruell, Kanika Vanshylla, Pinkus Tober-Lau, et al.
Pageof 8